Clinical and Biological Variables Influencing Outcome in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) Treated with Anti-PD-1/PD-L1 Antibodies: A Prospective Multicentre Study.
Erica QuaquariniFederico SottotettiFrancesco AgustoniEmma PozziAlberto MaloviniCristina Maria TeragniRaffaella PalumboGiuseppe SaltalamacchiaBarbara TagliaferriEmanuela BallettiPietro RinaldiCostanza CaninoPaolo PedrazzoliAntonio BernardoPublished in: Journal of personalized medicine (2022)
In the era of personalized medicine, the results are useful for stratifying the patients and tailoring the treatments, considering both the histological findings and the clinical features of the patients.